COST-EFFECTIVENESS OF FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY AND CHRONIC HEART FAILURE IN AUSTRIA

被引：4
|
作者：
Walter, E. [1 ]
Bauer, M. [1 ]
Ressl, S. [1 ]
机构：
[1] Inst Pharmaecon Res, Vienna, Austria
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.876
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV107
引用
收藏
页码：A392 / A392
页数：1
相关论文
共 50 条
  • [1] A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain
    Comin-Colet, Josep
    Rubio-Rodriguez, Dario
    Rubio-Terres, Carlos
    Enjuanes-Grau, Cristina
    Gutzwiller, Florian S.
    Anker, Stefan D.
    Ponikowski, Piotr
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (10): : 846 - 851
  • [2] Ferric carboxymaltose for patients with heart failure and iron deficiency in Italy: cost-effectiveness and budget impact
    Rognoni, Carla
    Gerzeli, Simone
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (13) : 1099 - 1110
  • [3] Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden
    Hofmarcher, Thomas
    Borg, Sixten
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (07) : 492 - 501
  • [4] COST-EFFECTIVENESS OF FERRIC CARBOXYMALTOSE FOR TREATING IRON DEFICIENCY ANEMIA IN CHINA
    Chuang, L. H.
    Sun, W.
    Serna, Ramirez de Arellano A.
    VALUE IN HEALTH, 2022, 25 (07) : S406 - S406
  • [5] Ferric Carboxymaltose in Heart Failure with Iron Deficiency
    Payan-Pernia, Salvador
    Perez-Simon, Jose Antonio
    Garcia-Erce, Jose Antonio
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (22): : 2108 - 2110
  • [6] Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost-effectiveness analysis utilising AFFIRM-AHF
    McEwan, Phil
    Ponikowski, Piotr
    Davis, Jason A.
    Rosano, Giuseppe
    Coats, Andrew J. S.
    Dorigotti, Fabio
    O'Sullivan, Donal
    de Arellano, Antonio Ramirez
    Jankowska, Ewa A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (10) : 1687 - 1697
  • [7] Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.
    Anker, Stefan D.
    Comin Colet, Josep
    Filippatos, Gerasimos
    Willenheimer, Ronnie
    Dickstein, Kenneth
    Drexler, Helmut
    Luescher, Thomas F.
    Bart, Boris
    Banasiak, Waldemar
    Niegowska, Joanna
    Kirwan, Bridget-Anne
    Mori, Claudio
    Rothe, Barbara von Eisenhart
    Pocock, Stuart J.
    Poole-Wilson, Philip A.
    Ponikowski, Piotr
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25): : 2436 - 2448
  • [8] Ferric Carboxymaltose in Heart Failure with Iron Deficiency
    Mentz, Robert J.
    Garg, Jyotsna
    Rockhold, Frank W.
    Butler, Javed
    De Pasquale, Carmine G.
    Ezekowitz, Justin A.
    Lewis, Gregory D.
    O'Meara, Eileen
    Ponikowski, Piotr
    Troughton, Richard W.
    Wong, Yee Weng
    She, Lilin
    Harrington, Josephine
    Adamczyk, Robert
    Blackman, Nicole
    Hernandez, Adrian F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (11): : 975 - 986
  • [9] Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
    van Veldhuisen, Dirk J.
    Ponikowski, Piotr
    van der Meer, Peter
    Metra, Marco
    Bohm, Michael
    Doletsky, Artem
    Voors, Adriaan A.
    Macdougall, Iain C.
    Anker, Stefan D.
    Roubert, Bernard
    Zakin, Lorraine
    Cohen-Solal, Alain
    CIRCULATION, 2017, 136 (15) : 1374 - +
  • [10] Cost-effectiveness of ferric carboxymaltose in patients with chronic heart failure: an analysis from the FAIR-HF trial
    Blank, P. R.
    Schwenkglenks, M.
    Szucs, T. D.
    EUROPEAN HEART JOURNAL, 2010, 31 : 225 - 225
12345